Complete metabolic response with letrozole and palbociclib in advanced breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Complete metabolic response with letrozole and palbociclib in advanced breast cancer

Published:2019-09-14 Issue: Volume:4 Page:82-84
ISSN:2456-3994
Container-title:International Journal of Molecular & Immuno Oncology
language:en
Short-container-title:IJMIO

Author:

Dhanushkodi Manikandan¹,Ananthi Balasubramanian²,Iyer Priya²

Affiliation:

1. Department of Medical Oncology, Cancer Institute (WIA), Chennai, Tamil Nadu, India,

2. Department of Radiation Oncology, Cancer Institute (WIA), Chennai, Tamil Nadu, India,

Abstract

We report a patient with hormone positive, HER2 negative advanced breast cancer with extensive metastasis who achieved complete metabolic remission with letrozole and palbociclib

Publisher

Scientific Scholar

Reference11 articles.

1. Palbociclib and letrozole in advanced breast cancer;Finn;N Engl J Med,2016

2. Ribociclib as first-line therapy for HR-positive, advanced breast cancer;Hortobagyi;N Engl J Med,2016

3. MONARCH 3: Abemaciclib as initial therapy for advanced breast cancer;Goetz;J Clin Oncol,2017

4. Cyclin-dependent kinase 4/6 inhibitors in breast cancer: palbociclib, ribociclib, and abemaciclib;Kwapisz;Breast Cancer Res. Treat,2017

5. Recurrent and metastatic breast cancer PET, PET/ CT, PET/MRI: FDG and new biomarkers;Gaeta;Q J Nucl Med Mol Imaging,2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP